Immunomedics

0 DAYS LEFT TO SEEK LEAD PLAINTIFF STATUS

Case Summary
Company Name: Immunomedics
Stock Symbol : NASDAQ: IMMU
Class Period Start: 08/23/2018
Class Period End: 12/20/2018
Lead Plaintiff motion: 02/25/2019
Date Filed: 12/27/2018
Type of Case: Securities Class Action
Court: U.S. District Court for the District of New Jersey
Summary:

Thieler Law Corp advises investors with losses exceeding $100,000 of the February 25, 2019 lead plaintiff deadline in a class action lawsuit filed against Immunomedics Inc (NASDAQ: IMMU) (“Immunomedics” or “the Company”). The suit is pending in the U.S. District Court for the District of New Jersey and investors, who purchased Immunomedics Inc securities between August 23, 2018 and December 20, 2018, have until February 25, 2019 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class.

If you purchased Immunomedics Inc securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class.

The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose material adverse facts.

The Complaint alleges that on December 17, 2018, an article published by FDAnews.com entitled “FDA Hits Immunomedics for Data Integrity Breach” reported, in part, that “[t]he FDA cited Immunomedics for a host of violations—including its handling of a data integrity breach—observed at its Morris Plains, New Jersey, drug substance manufacturing facility between August 6 and 14.” 

Furthermore, according to the article, the data breach included “manipulated bioburden samples, misrepresentation of an integrity test procedure in the batch record, and backdating of batch records, such as dates of analytical results.” 

On this news, NASDAQ: IMMU fell sharply, damaging investors.

If you were negatively impacted by your investment in Immunomedics Inc securities between August 23, 2018 and December 20, 2018 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Materials are provided for informational purposes only and do not constitute legal advice. We are only licensed to practice law in Germany. We are neither licensed nor qualified to render advice on US Federal or State law.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/

or

Facsimile: +1 (619) 785 – 3185

Transactions
Buy date (mm/dd/yyyy) Number of shares Price per share
Sell date (mm/dd/yyyy) Number of shares Price per share
Please wait...